Treatment of severe acne with low-dose isotretinoin

Acta Dermato-Venereologica

Volumn 92, Issue 3, 2012, Pages 247-248

  Mehra, Tarun ^a   Borelli, Claudia ^a   Burgdorf, Walter ^b   Röcken, Martin ^a   Schaller, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; ISOTRETINOIN;

ACNE CONGLOBATA; ACNE FULMINANS; ADOLESCENT; ADULT; CHEILITIS; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ACNE VULGARIS; ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CLINDAMYCIN; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FEMALE; HUMANS; ISOTRETINOIN; MALE; NAPHTHALENES; PHOTOGRAPHY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84859751206     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1325     Document Type: Letter

References (15)

1. Plewig G, Kligman AM. Acne and rosacea. 3rd edition. Berlin: Springer Verlag, 2000.
2. Zaba R, Schwartz R, Jarmuda S, Czarnecka-Operacz M, Silny W. Acne fulminans: explosive systemic form of acne. J Eur Acad Dermatol Venereol 2011; 25: 501-507.
3. Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, Xia L, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009; 18: 821-832.
4. Melnik BC, Schmitz G, Zouboulis CC. Anti-acne agents attenuate FGFR2 signal transduction in acne. J Invest Dermatol 2009; 129: 1868-1877.
5. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 2005; 166: 1691-1699.
6. Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, et al. Guidelines of care for acne vulgaris management. JAAD 2007; 56: 651-663.
7. Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Arch Dermatol 1979; 115: 571-575.
8. James WD. Clinical practice. Acne. N Engl J Med 2005; 352: 1463-1472.
9. Goodfield MJD, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, et al. Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010. Br J Dermatol 2010; 162: 1172-1179.
10. Barth JH, Macdonald-Hull SP, Mark J, Jones RG, Cunliffe WJ. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129: 704-707.
11. Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V. Acute acne flare following isotretinoin administration: potential protective role of low starting dose. Dermatology 2009; 218: 178-180.
12. Plewig G, Dressel H, Pfleger M, Michelsen S, Kligman AM. Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne. J Dtsch Dermatol Ges 2004; 2: 31-45.
13. Lee JW, Yoo KH, Park KY, Han TY, Li K, Seo SJ, et al. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol 2011; 164: 1369-1375.
14. Karvonen SL, Vaalasti A, Kautiainen H, Reunala T. Systemic corticosteroid and isotretinoin treatment in cystic acne. Acta Derm Venereol 1993; 73: 452-455.
15. Melnik BC. Isotretinoin and FoxO1: a scientific hypothesis. Dermatoendocrinol 2011; 3: 141-165.